NO20031692L - Fremgangsmåte for fremstilling av pulverformuleringer - Google Patents

Fremgangsmåte for fremstilling av pulverformuleringer

Info

Publication number: NO20031692L
Authority: NO; Norway
Prior art keywords: preparation; powder formulations; formulations; powder
Prior art date: 2000-10-12

Application number

NO20031692A

Other languages

English (en)

Other versions

NO333719B1 (no

NO20031692D0 (no

Inventor

Georg Boeck

Michael Walz

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2003-04-11

Publication date

2003-06-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031692(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-08-10 Priority claimed from DE2001138022 external-priority patent/DE10138022A1/de

2003-04-11 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-04-11 Publication of NO20031692D0 publication Critical patent/NO20031692D0/no

2003-06-06 Publication of NO20031692L publication Critical patent/NO20031692L/no

2013-09-02 Publication of NO333719B1 publication Critical patent/NO333719B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Detergent Compositions (AREA)
Cosmetics (AREA)

NO20031692A 2000-10-12 2003-04-11 Fremgangsmate for fremstilling av pulverformuleringer NO333719B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10050635		2000-10-12
DE2001138022 DE10138022A1 (de)	2001-08-10	2001-08-10	Verfahren zur Herstellung von Pulverformulierungen
PCT/EP2001/011636 WO2002030390A2 (de)	2000-10-12	2001-10-09	Verfahren zur herstellung von pulverformulierungen

Publications (3)

Publication Number	Publication Date
NO20031692D0 NO20031692D0 (no)	2003-04-11
NO20031692L true NO20031692L (no)	2003-06-06
NO333719B1 NO333719B1 (no)	2013-09-02

Family

ID=26007343

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031692A NO333719B1 (no)	2000-10-12	2003-04-11	Fremgangsmate for fremstilling av pulverformuleringer

Country Status (39)

Country	Link
US (2)	US6585959B2 (no)
EP (1)	EP1326585B2 (no)
JP (2)	JP4986369B2 (no)
KR (1)	KR100849837B1 (no)
CN (1)	CN1269470C (no)
AR (1)	AR034166A1 (no)
AT (1)	ATE319422T1 (no)
AU (2)	AU2002218220B2 (no)
BG (1)	BG66194B1 (no)
BR (1)	BR0114316A (no)
CA (1)	CA2425005C (no)
CY (1)	CY1105037T1 (no)
CZ (1)	CZ300022B6 (no)
DE (1)	DE50109178D1 (no)
DK (1)	DK1326585T4 (no)
EA (1)	EA004689B1 (no)
EE (1)	EE05146B1 (no)
EG (1)	EG24478A (no)
ES (1)	ES2259046T5 (no)
HR (1)	HRP20030277B1 (no)
HU (1)	HU229512B1 (no)
IL (2)	IL154919A0 (no)
ME (1)	ME02762B (no)
MX (1)	MXPA03003219A (no)
MY (1)	MY155912A (no)
NO (1)	NO333719B1 (no)
NZ (1)	NZ525781A (no)
PE (1)	PE20020424A1 (no)
PL (1)	PL204733B1 (no)
PT (1)	PT1326585E (no)
RS (1)	RS50495B (no)
SA (1)	SA01220518B1 (no)
SI (1)	SI1326585T2 (no)
SK (1)	SK285841B6 (no)
TW (1)	TWI283180B (no)
UA (1)	UA75375C2 (no)
UY (1)	UY26960A1 (no)
WO (1)	WO2002030390A2 (no)
ZA (1)	ZA200301349B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ3477A1 (no) *	2000-10-12	2002-04-18
US6443152B1 (en) *	2001-01-12	2002-09-03	Becton Dickinson And Company	Medicament respiratory delivery device
CA2445650A1 (en) *	2001-05-25	2002-12-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US20030008001A1 (en) *	2001-06-13	2003-01-09	Boehringer Ingelheim Pharma Kg	Process for cleaning hard gelatine capsules
US20030018019A1 (en) *	2001-06-23	2003-01-23	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de)	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) *	2001-08-23	2003-03-13	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Inhalationspulvern
US7309707B2 (en) *	2002-03-20	2007-12-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) *	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
MXPA04009583A (es) *	2002-04-04	2005-01-11	Boehringer Ingelheim Pharma	Nuevas formulaciones en polvo adecuadas para inhalacion.
GB0219513D0 (en)	2002-08-21	2002-10-02	Norton Healthcare Ltd	Inhalation compositions including coarse carrier
US20050158248A1 (en) *	2002-08-21	2005-07-21	Xian-Ming Zeng	Method of preparing dry powder inhalation compositions
JP4744876B2 (ja) *	2002-08-21	2011-08-10	ノートン・ヘルスケアーリミテッド	乾燥粉末吸入組成物の製造方法
MXPA05001903A (es) *	2002-08-21	2005-04-28	Norton Healthcare Ltd	Composicion para inhalacion.
GB0219511D0 (en) *	2002-08-21	2002-10-02	Norton Healthcare Ltd	Method of preparing dry powder inhalation compositions
US7763280B2 (en)	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) *	2002-11-28	2004-06-09	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Tiotropium-haltige Pulverformulierung für die Inhalation
UA83813C2 (ru) *	2002-12-20	2008-08-26	Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг	Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en)	2003-05-13	2004-11-18	Deem Mark E.	Apparatus for treating asthma using neurotoxin
US7462367B2 (en)	2003-07-11	2008-12-09	Boehringer Ingelheim International Gmbh	Anticholinergic powder formulations for inhalation
DE10331350A1 (de) *	2003-07-11	2005-01-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
DK1699434T3 (da) *	2003-09-02	2011-05-30	Norton Healthcare Ltd	Fremgangsmåde til fremstilling af et lægemiddel
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US8686148B2 (en)	2003-11-03	2014-04-01	Boehringer Ingelheim International Gmbh	Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
PE20050485A1 (es)	2003-11-03	2005-10-05	Boehringer Ingelheim Int	Nuevas sales de tiotropio, procedimiento para su preparacion, asi como formulaciones medicamentosas que las contienen
CA2547245A1 (en) *	2003-12-03	2005-06-16	Microdrug Ag	Pre-metered dry powder inhaler for moisture-sensitive medicaments
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US9365905B2 (en)	2005-02-10	2016-06-14	Dmv-Fonterra Excipients Technology Gmbh	Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0507835D0 (en) *	2005-04-18	2005-05-25	Solexa Ltd	Method and device for nucleic acid sequencing using a planar wave guide
WO2006117299A2 (en)	2005-05-02	2006-11-09	Boehringer Ingelheim International Gmbh	Novel crystalline forms of tiotropium bromide
DE102005059602A1 (de)	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
ES2569359T3 (es)	2007-07-06	2016-05-10	Vectura Delivery Devices Limited	Inhalador
US20100255307A1 (en) *	2007-07-27	2010-10-07	Cargill Inc.	Micronization of polyols
EP2082768A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082767A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082766A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Blister Strip Coil Forming
EP2082771A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082772A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
US8483831B1 (en)	2008-02-15	2013-07-09	Holaira, Inc.	System and method for bronchial dilation
EP2662116B1 (en)	2008-05-09	2022-09-21	Nuvaira, Inc.	Systems and assemblies for treating a bronchial tree
TWI470107B (zh) *	2008-07-24	2015-01-21	液態空氣喬治斯克勞帝方法研究開發股份有限公司	用於沉積含過渡金屬之膜的環戊二烯基過渡金屬前驅物
TWI491416B (zh)	2008-12-24	2015-07-11	Daiichi Sankyo Co Ltd	吸入用乾燥粉末醫藥組成物
GB0918450D0 (en)	2009-10-21	2009-12-09	Innovata Ltd	Composition
WO2011056684A2 (en)	2009-10-27	2011-05-12	Innovative Pulmonary Solutions, Inc.	Delivery devices with coolable energy emitting assemblies
CA2780608C (en)	2009-11-11	2019-02-26	Innovative Pulmonary Solutions, Inc.	Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en)	2009-11-11	2014-12-16	Holaira, Inc.	Non-invasive and minimally invasive denervation methods and systems for performing the same
EP2575786B1 (en)	2010-06-03	2017-11-15	Sima Patent ve Lisanslama Hizmetleri Ltd.Sti.	Process for dry powder formulations
TR201007251A2 (tr) *	2010-09-01	2012-03-21	Bi̇lgi̇ç Mahmut	Kalsiyum kanal blokörü formülasyonu.
US9398933B2 (en)	2012-12-27	2016-07-26	Holaira, Inc.	Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2016005443A1 (en)	2014-07-09	2016-01-14	Arven Ilac Sanayi Ve Ticaret A.S.	A process for the preparation of formulations for inhalation
PL3175842T3 (pl) *	2015-12-03	2020-06-29	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Sposób mieszania suchego proszku
WO2020013793A2 (en) *	2018-07-12	2020-01-16	Arven Ilac Sanayi Ve Ticaret Anonim Sirketi	Inhalation compositions comprising dopamine agonists
WO2022146255A1 (en) *	2020-12-31	2022-07-07	Arven Ilac Sanayi Ve Ticaret Anonim Sirketi	A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1242211A (en)	1967-08-08	1971-08-11	Fisons Pharmaceuticals Ltd	Pharmaceutical composition
US3860618A (en)	1967-08-08	1975-01-14	Philip Saxton Hartley	Chromone
US3957965A (en)	1967-08-08	1976-05-18	Fisons Limited	Sodium chromoglycate inhalation medicament
BE891013A (fr) †	1980-11-05	1982-05-05	Fisons Ltd	Compositions pharmaceutique
JPS60150823A (ja) *	1984-01-17	1985-08-08	Satake Eng Co Ltd	穀物混合装置
JPH0439388A (ja) *	1990-06-04	1992-02-10	Teijin Ltd	土砂と繊維状物との混合方法
DE4140689B4 (de) *	1991-12-10	2007-11-22	Boehringer Ingelheim Kg	Inhalationspulver und Verfahren zu ihrer Herstellung
JPH06198156A (ja) *	1993-01-06	1994-07-19	Nagasaki Pref Gov	噴霧積層混合器
IS1796B (is) *	1993-06-24	2001-12-31	Ab Astra	Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
GB9322014D0 (en)	1993-10-26	1993-12-15	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en)	1994-03-15	1994-04-27	Glaxo Group Ltd	Pharmaceutical composition
DE4425255A1 (de) *	1994-07-16	1996-01-18	Asta Medica Ag	Formulierung zur inhalativen Applikation
NZ511527A (en)	1998-11-13	2002-10-25	Jago Res A	Dry powder for inhalation
GB9902689D0 (en)	1999-02-08	1999-03-31	Novartis Ag	Organic compounds

2001
- 2001-09-10 UA UA2003054184A patent/UA75375C2/uk unknown
- 2001-10-09 BR BR0114316-6A patent/BR0114316A/pt not_active Application Discontinuation
- 2001-10-09 ME MEP-2008-427A patent/ME02762B/me unknown
- 2001-10-09 CA CA 2425005 patent/CA2425005C/en not_active Expired - Lifetime
- 2001-10-09 CN CNB01817146XA patent/CN1269470C/zh not_active Expired - Lifetime
- 2001-10-09 AU AU2002218220A patent/AU2002218220B2/en not_active Expired
- 2001-10-09 SI SI200130509T patent/SI1326585T2/sl unknown
- 2001-10-09 DE DE50109178T patent/DE50109178D1/de not_active Expired - Lifetime
- 2001-10-09 PT PT01986599T patent/PT1326585E/pt unknown
- 2001-10-09 NZ NZ525781A patent/NZ525781A/en not_active IP Right Cessation
- 2001-10-09 AT AT01986599T patent/ATE319422T1/de active
- 2001-10-09 EE EEP200300170A patent/EE05146B1/xx unknown
- 2001-10-09 ES ES01986599T patent/ES2259046T5/es not_active Expired - Lifetime
- 2001-10-09 EA EA200300429A patent/EA004689B1/ru not_active IP Right Cessation
- 2001-10-09 KR KR1020037005039A patent/KR100849837B1/ko not_active Expired - Lifetime
- 2001-10-09 RS YUP-274/03A patent/RS50495B/sr unknown
- 2001-10-09 SK SK437-2003A patent/SK285841B6/sk not_active IP Right Cessation
- 2001-10-09 TW TW090124981A patent/TWI283180B/zh not_active IP Right Cessation
- 2001-10-09 MX MXPA03003219A patent/MXPA03003219A/es active IP Right Grant
- 2001-10-09 EP EP01986599A patent/EP1326585B2/de not_active Expired - Lifetime
- 2001-10-09 HR HR20030277A patent/HRP20030277B1/xx not_active IP Right Cessation
- 2001-10-09 IL IL15491901A patent/IL154919A0/xx active IP Right Grant
- 2001-10-09 WO PCT/EP2001/011636 patent/WO2002030390A2/de not_active Ceased
- 2001-10-09 JP JP2002533833A patent/JP4986369B2/ja not_active Expired - Lifetime
- 2001-10-09 HU HU0301268A patent/HU229512B1/hu unknown
- 2001-10-09 PL PL362511A patent/PL204733B1/pl unknown
- 2001-10-09 AU AU1822002A patent/AU1822002A/xx active Pending
- 2001-10-09 DK DK01986599.7T patent/DK1326585T4/da active
- 2001-10-09 CZ CZ20031024A patent/CZ300022B6/cs not_active IP Right Cessation
- 2001-10-10 MY MYPI20014704A patent/MY155912A/en unknown
- 2001-10-10 EG EG2001101063A patent/EG24478A/xx active
- 2001-10-10 PE PE2001001002A patent/PE20020424A1/es active IP Right Grant
- 2001-10-10 UY UY26960A patent/UY26960A1/es not_active IP Right Cessation
- 2001-10-11 US US09/977,911 patent/US6585959B2/en not_active Ceased
- 2001-10-12 AR ARP010104784A patent/AR034166A1/es unknown
- 2001-11-11 SA SA01220518A patent/SA01220518B1/ar unknown
2003
- 2003-02-19 ZA ZA2003/01349A patent/ZA200301349B/en unknown
- 2003-03-13 IL IL154919A patent/IL154919A/en unknown
- 2003-03-26 BG BG107673A patent/BG66194B1/bg unknown
- 2003-04-11 NO NO20031692A patent/NO333719B1/no not_active IP Right Cessation
2004
- 2004-01-28 US US10/766,748 patent/USRE38912E1/en not_active Expired - Lifetime
2006
- 2006-05-19 CY CY20061100654T patent/CY1105037T1/el unknown
2009
- 2009-06-08 JP JP2009136927A patent/JP2009197025A/ja active Pending

Also Published As

Publication number	Publication date
DE50109178D1 (de)	2006-05-04
AU2002218220B2 (en)	2006-06-15
EP1326585B1 (de)	2006-03-08
PL362511A1 (en)	2004-11-02
BR0114316A (pt)	2003-08-26
EA004689B1 (ru)	2004-06-24
RS50495B (sr)	2010-03-02
USRE38912E1 (en)	2005-12-06
MY155912A (en)	2015-12-15
EP1326585A2 (de)	2003-07-16
SK285841B6 (sk)	2007-09-06
AR034166A1 (es)	2004-02-04
SK4372003A3 (en)	2003-07-01
UA75375C2 (en)	2006-04-17
EA200300429A1 (ru)	2003-10-30
WO2002030390A2 (de)	2002-04-18
HUP0301268A3 (en)	2005-05-30
JP2009197025A (ja)	2009-09-03
YU27403A (sh)	2006-03-03
US6585959B2 (en)	2003-07-01
HRP20030277A2 (en)	2005-02-28
CZ300022B6 (cs)	2009-01-14
HU229512B1 (en)	2014-01-28
IL154919A (en)	2011-01-31
CA2425005C (en)	2008-08-05
SA01220518B1 (ar)	2006-12-10
KR20030051706A (ko)	2003-06-25
SI1326585T2 (sl)	2011-01-31
MEP42708A (en)	2011-02-10
EG24478A (en)	2009-08-03
HK1060522A1 (en)	2004-08-13
CA2425005A1 (en)	2003-04-04
ME02762B (me)	2011-05-10
PT1326585E (pt)	2006-05-31
EP1326585B2 (de)	2010-09-29
UY26960A1 (es)	2002-06-20
EE200300170A (et)	2003-06-16
CN1269470C (zh)	2006-08-16
JP4986369B2 (ja)	2012-07-25
NO333719B1 (no)	2013-09-02
DK1326585T4 (da)	2011-01-10
ATE319422T1 (de)	2006-03-15
PE20020424A1 (es)	2002-07-02
IL154919A0 (en)	2003-10-31
ZA200301349B (en)	2004-06-30
BG66194B1 (bg)	2012-01-31
ES2259046T5 (es)	2011-02-28
NZ525781A (en)	2004-11-26
NO20031692D0 (no)	2003-04-11
TWI283180B (en)	2007-07-01
PL204733B1 (pl)	2010-02-26
HUP0301268A2 (hu)	2003-10-28
HRP20030277B1 (en)	2011-09-30
WO2002030390A3 (de)	2002-06-27
MXPA03003219A (es)	2004-12-03
JP2004510806A (ja)	2004-04-08
KR100849837B1 (ko)	2008-08-01
CY1105037T1 (el)	2010-03-03
AU1822002A (en)	2002-04-22
DK1326585T3 (da)	2006-05-22
SI1326585T1 (sl)	2006-06-30
EE05146B1 (et)	2009-04-15
ES2259046T3 (es)	2006-09-16
BG107673A (bg)	2003-11-28
US20020106332A1 (en)	2002-08-08
CN1469733A (zh)	2004-01-21

Publication	Publication Date	Title
NO20031692D0 (no)	2003-04-11	Fremgangsmåte for fremstilling av pulverformuleringer
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NL300305I2 (nl)	2008-02-01	Werkwijze voor de bereiding van gesubstitueerde octanoylamides
NO20013942D0 (no)	2001-08-14	Fremgangsmate for fremstilling av Citalopram
FI20011578A0 (fi)	2001-07-26	Menetelmä puhtaan sitalopraamin valmistamiseksi
NO20011271A (no)	2002-05-13	Fremgangsmåte for fremstilling av ren citalopram
NO20031229L (no)	2003-03-17	Fremgangsmåte for fremstilling av börstevarer
NO20032731D0 (no)	2003-06-16	Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
IL187126A0 (en)	2008-02-09	Process for the preparation of 4 - haloalkylnicotinonitriles
NO20025423L (no)	2002-11-12	Fremgangsmate for fremstilling av Citalopram
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
HUP0303055A3 (en)	2004-11-29	Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them
NO20021118D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av citalopram
EP1176150A4 (en)	2003-04-23	A METHOD FOR PRODUCING TRIFLUOROTHYMIDINE DERIVATIVES
NO20024887D0 (no)	2002-10-10	Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
IL150897A0 (en)	2003-02-12	Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
IL190807A0 (en)	2008-11-03	Process for the preparation of 2-aminoethylpyridines
NO20032297D0 (no)	2003-05-21	Fremgangsmåte for fremstilling av distamycinderivater
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
AU2002240835A1 (en)	2002-07-16	Process for the manufacture of solid formulations
NO20025385L (no)	2002-11-11	Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
GB0031831D0 (en)	2001-02-14	Process for the manufacture of solid formulations
NO20002558D0 (no)	2000-05-18	FremgangsmÕte for fremstilling av findisperse eksplosivstoffer

Legal Events

Date	Code	Title	Description
2021-11-08	MK1K	Patent expired